94 related articles for article (PubMed ID: 29901180)
1. MG‑132 reverses multidrug resistance by activating the JNK signaling pathway in FaDu/T cells.
Ma J; Lv Z; Liu X; Liu X; Xu W
Mol Med Rep; 2018 Aug; 18(2):1820-1825. PubMed ID: 29901180
[TBL] [Abstract][Full Text] [Related]
2. [Role of ABCB1 and ABCG2 in the multidrug resistance of hypopharyngeal carcinoma FaDu cell line].
MA JK; LU SM; YU L; TIAN JJ; LI JF; WANG HB; XU W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):305-10. PubMed ID: 22800348
[TBL] [Abstract][Full Text] [Related]
3. MG132 reverse the malignant characteristics of hypopharyngeal cancer.
Ma J; Yu L; Tian J; Mu Y; Lv Z; Zou J; Li J; Wang H; Xu W
Mol Med Rep; 2014 Jun; 9(6):2587-91. PubMed ID: 24691740
[TBL] [Abstract][Full Text] [Related]
4. FaDu cell characteristics induced by multidrug resistance.
Ma J; Lu S; Yu L; Tian J; Li J; Wang H; Xu W
Oncol Rep; 2011 Nov; 26(5):1189-95. PubMed ID: 21833476
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
[TBL] [Abstract][Full Text] [Related]
6. Cepharanthine hydrochloride reverses P‑glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780/Taxol cells by inhibiting the PI3K/Akt signaling pathway.
Huang CZ; Wang YF; Zhang Y; Peng YM; Liu YX; Ma F; Jiang JH; Wang QD
Oncol Rep; 2017 Oct; 38(4):2558-2564. PubMed ID: 28791369
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV downregulates the expression of MDR1 in Bel‑7402/FU human hepatic cancer cells by inhibiting the JNK/c‑Jun/AP‑1 signaling pathway.
Wang PP; Luan JJ; Xu WK; Wang L; Xu DJ; Yang CY; Zhu YH; Wang YQ
Mol Med Rep; 2017 Sep; 16(3):2761-2766. PubMed ID: 28713943
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibitor MG132 reverses multidrug resistance of gastric cancer through enhancing apoptosis and inhibiting P-gp.
Zhang Y; Shi Y; Li X; Du R; Luo G; Xia L; Du W; Chen B; Zhai H; Wu K; Fan D
Cancer Biol Ther; 2008 Apr; 7(4):540-6. PubMed ID: 18296917
[TBL] [Abstract][Full Text] [Related]
9. Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells.
Lu S; Yu L; Mu Y; Ma J; Tian J; Xu W; Wang H
Mol Med Rep; 2014 Jul; 10(1):53-60. PubMed ID: 24805866
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
11. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells.
Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of NPM reverses multidrug resistance in human hepatoma cells via inhibition of P-glycoprotein expression.
Luo F; Li H; Liang J; Jia H; Li X; Xiao H; He X; He J; Tian Y; Zhao H
Mol Med Rep; 2017 Apr; 15(4):2360-2368. PubMed ID: 28259962
[TBL] [Abstract][Full Text] [Related]
13. Asclepiasterol, a novel C21 steroidal glycoside derived from Asclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression.
Yuan WQ; Zhang RR; Wang J; Ma Y; Li WX; Jiang RW; Cai SH
Oncotarget; 2016 May; 7(21):31466-83. PubMed ID: 27129170
[TBL] [Abstract][Full Text] [Related]
14. Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer.
Yuan ZT; Shi XJ; Yuan YX; Qiu YY; Zou Y; Liu C; Yu H; He X; Xu K; Yin PH
Oncotarget; 2017 Jul; 8(29):48012-48026. PubMed ID: 28624793
[TBL] [Abstract][Full Text] [Related]
15. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
[TBL] [Abstract][Full Text] [Related]
16. Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1.
Wang SQ; Liu ST; Zhao BX; Yang FH; Wang YT; Liang QY; Sun YB; Liu Y; Song ZH; Cai Y; Li GF
Oncotarget; 2015 Sep; 6(28):26142-60. PubMed ID: 26317651
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells.
Sui H; Fan ZZ; Li Q
J Int Med Res; 2012; 40(2):426-35. PubMed ID: 22613403
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
Susa M; Choy E; Yang C; Schwab J; Mankin H; Hornicek F; Duan Z
J Biomol Screen; 2010 Mar; 15(3):287-96. PubMed ID: 20150589
[TBL] [Abstract][Full Text] [Related]
19. Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling.
Lu Y; Li F; Xu T; Sun J
Int J Mol Med; 2017 Apr; 39(4):993-1000. PubMed ID: 28260091
[TBL] [Abstract][Full Text] [Related]
20. The Limitations of Collagen/CPP Hybrid Peptides as Carriers for Cancer Drugs to FaDu Cells.
Ho K; Morfin C; Slowinska K
Molecules; 2019 Feb; 24(4):. PubMed ID: 30769789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]